Redux Electrolyte Creme, Product Ref. 66-04. Highly conductive electrolyte creme.
Published May 1, 2024 · Recall initiated: March 22, 2024
Summary
FDA records medical device Class II recall Z-1604-2024, published May 1, 2024 and initiated March 22, 2024. Recalling firm: Parker Laboratories, Inc.; Status: Ongoing; Reported quantity: 217 cases (1,085 Inner Boxes; 10,850 Eaches); Lot: Product No. 66-04; UDI: 20855683006399 (Master), 10855683006392 (Inner Box), 00855683006395 (Each); Lot No. (Expiration Date): A1122010 (11/29/25) and A0523002 (5/12/26). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Product demonstrates low viscosity.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Parker Laboratories, Inc.
- Distributor
- Worldwide distribution - US Nationwide in the states of CA, CO, FL, GA, IL, MD, MI, MN, NC, NE, NY, OH, PA, SC, & TX. The countries of AU, CA, OM, & SA.
- Lot
- Product No. 66-04; UDI: 20855683006399 (Master), 10855683006392 (Inner Box), 00855683006395 (Each); Lot No. (Expiration Date): A1122010 (11/29/25) and A0523002 (5/12/26).
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAIBA Proton Therapy System - PROTEUS 235, PTS-10 versions, PTS-11 versions, and PTS-12 versions.May 1, 2024
- FDAMariner RDX Polyaxial Head, REF: MX1-000020; Mariner RDX Extended Polyaxial Head, REF: MX1-000030; Mariner RDXMay 1, 2024
- FDATensive Conductive Adhesive Gel, Product Ref. 22-60. 12, 1 case contains 12 inner boxes with 50g tubesMarch 6, 2024
- FDAHelix Pain Relieving Cream (Menthol 7.4%), packaged in a) 5 gm pouch (NDC 30775-051-01), b) 3 fl. oz. roll-onAugust 30, 2023
- FDAHelix Tri-Active Therapy Cream (Camphor 3.2%, Menthol 7.4%, Methyl salicylate 12.5%), packaged in a) 3 fl. oz.August 30, 2023
- FDAProtex Foaming Hand Sanitizer (Benzalkonium Chloride 0.13%), packaged in a) 2 fl oz/60 mL Pump bottles (NDCAugust 30, 2023
Questions about this recall
Was Redux Electrolyte Creme, Product Ref. 66-04. Highly conductive electrolyte creme. recalled?
Yes. FDA published recall Z-1604-2024 on May 1, 2024. Reported hazard: Product demonstrates low viscosity.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail